Literature DB >> 15879573

Targeted deletion of the SPARC gene accelerates disc degeneration in the aging mouse.

Helen E Gruber1, E Helene Sage, H James Norton, Sarah Funk, Jane Ingram, Edward N Hanley.   

Abstract

SPARC (secreted protein, acidic, and rich in cysteine) is a matricellular protein that is present in the intervertebral disc; in man, levels of SPARC decrease with aging and degeneration. In this study, we asked whether targeted deletion of SPARC in the mouse influenced disc morphology. SPARC-null and wild-type (WT) mice were studied at 0.3-21 months of age. Radiologic examination of spines from 2-month-old SPARC-null mice revealed wedging, endplate calcification, and sclerosis, features absent in age-matched WT spines. Discs from 3-month-old SPARC-null mice had a greater number of annulus cells than those of WT animals (1884.6 +/- 397.9 [mean +/- SD] vs 1500.2 +/- 188.2, p=0.031). By 19 months discs from SPARC-null mice contained fewer cells than WT counterparts (1383.6 +/- 363.3 vs 1466.8 +/- 148.0, p=0.033). Histology of midsagittal spines showed herniations of lower lumbar discs of SPARC-null mice ages 14-19 months; in contrast, no herniations were seen in WT age-matched animals. Ultrastructural studies showed uniform collagen fibril diameters in the WT annulus, whereas in SPARC-null disc fibrils were of variable size with irregular margins. Consistent with the connective tissue deficits observed in other tissues of SPARC-null mice, our findings support a fundamental role for SPARC in the production, assembly, or maintenance of the disc extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879573     DOI: 10.1369/jhc.5A6687.2005

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  33 in total

1.  Functional role of periostin in development and wound repair: implications for connective tissue disease.

Authors:  Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2008-07-20       Impact factor: 5.782

2.  Sparc protein is required for normal growth of zebrafish otoliths.

Authors:  Young-Jin Kang; Amy K Stevenson; Peter M Yau; Richard Kollmar
Journal:  J Assoc Res Otolaryngol       Date:  2008-09-11

Review 3.  Prospects for the development of epigenetic drugs for CNS conditions.

Authors:  Moshe Szyf
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

Review 4.  Drugging the pain epigenome.

Authors:  Ellen Niederberger; Eduard Resch; Michael J Parnham; Gerd Geisslinger
Journal:  Nat Rev Neurol       Date:  2017-05-26       Impact factor: 42.937

5.  The aging mouse partially models the aging human spine: lumbar and coccygeal disc height, composition, mechanical properties, and Wnt signaling in young and old mice.

Authors:  Nilsson Holguin; Rhiannon Aguilar; Robin A Harland; Bradley A Bomar; Matthew J Silva
Journal:  J Appl Physiol (1985)       Date:  2014-05-01

Review 6.  SPARC/osteonectin in mineralized tissue.

Authors:  Emilie M Rosset; Amy D Bradshaw
Journal:  Matrix Biol       Date:  2016-02-03       Impact factor: 11.583

7.  Recessive osteogenesis imperfecta caused by missense mutations in SPARC.

Authors:  Roberto Mendoza-Londono; Somayyeh Fahiminiya; Jacek Majewski; Martine Tétreault; Javad Nadaf; Peter Kannu; Etienne Sochett; Andrew Howard; Jennifer Stimec; Lucie Dupuis; Paul Roschger; Klaus Klaushofer; Telma Palomo; Jean Ouellet; Hadil Al-Jallad; John S Mort; Pierre Moffatt; Sergei Boudko; Hans-Peter Bächinger; Frank Rauch
Journal:  Am J Hum Genet       Date:  2015-05-28       Impact factor: 11.025

8.  SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling.

Authors:  Jing Nie; E Helene Sage
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

9.  SPARC accelerates disease progression in experimental crescentic glomerulonephritis.

Authors:  Amy N Sussman; Tong Sun; Ronald M Krofft; Raghu V Durvasula
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.